Fundraising FoxPelican Therapeutics
Austin, US · Delaware corporation
Find your way into Pelican Therapeutics
Sign up to see every warm intro you have to Pelican Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pelican Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TS
Taylor SchreiberNamed on SEC filing
Board
JW
Jeffrey WolfBoard director
NP
Nico PronkBoard director
EB
Edward B. SmithBoard director
RJ
Rahul JasujaBoard director
JM
Jules MusingBoard director
SM
Shawn M. TitcombBoard director
Reported raises · per SEC filings
Form D private placements$410K disclosed across 2 rounds · 2014–2015
▶$250KraisedAug 2015 · 3 investors · BiotechnologyRule 506(b)
▶$250KraisedAug 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Edward B. SmithDirector
- Rahul JasujaDirector
- Josiah HornblowerExecutive Officer, Director
- Jeffrey WolfDirector
- Taylor SchreiberDirector
- Offering amount
- $1M
- Amount sold
- $250K
- Minimum investment
- $25K
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$160KraisedJun 2014 · 3 investors · BiotechnologyRule 506(b)
▶$160KraisedJun 2014 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jules MusingDirector
- Shawn M. TitcombDirector
- Jeffrey WolfDirector
- Edward B. SmithDirector
- Taylor H. SchreiberDirector
- Nico PronkDirector
- Josiah HornblowerExecutive Officer, Director
- Offering amount
- $850K
- Amount sold
- $160K
- Minimum investment
- $5K
- Proceeds to insiders
- $110K
- Placement agents
- Noble Financial Capital Markets
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $224.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Pelican Therapeutics raised?
- Pelican Therapeutics has disclosed $410K raised across 2 rounds.
- Where is Pelican Therapeutics headquartered?
- Pelican Therapeutics is headquartered in Austin, US.